Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Askar Obulkasim; Bauke Ylstra; Hendrik F. van Essen; Christian Benner; Sally Stenning; Ruth Langley; William Allum; David Cunningham; Imran Inam; Lindsay C. Hewitt; Nicolas P. West; Gerrit A. Meijer; Mark A. van de Wiel; Heike I. Grabsch

doi:https://doi.org/10.18632/oncotarget.9857

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Askar Obulkasim, Bauke Ylstra, Hendrik F. van Essen, Christian Benner, Sally Stenning, Ruth Langley, William Allum, David Cunningham, Imran Inam, Lindsay C. Hewitt, Nicolas P. West, Gerrit A. Meijer, Mark A. van de Wiel, Heike I. Grabsch

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	44084-44095
Journal	Oncotarget
Volume	7
Issue number	28
DOIs	https://doi.org/10.18632/oncotarget.9857
Publication status	Published - 12 Jul 2016

Keywords

array CGH
chemotherapy
esophageal adenocarcinoma
prognosis

Access to Document

https://doi.org/10.18632/oncotarget.9857

Cite this

Obulkasim, A., Ylstra, B., van Essen, H. F., Benner, C., Stenning, S., Langley, R., Allum, W., Cunningham, D., Inam, I., Hewitt, L. C., West, N. P., Meijer, G. A., van de Wiel, M. A., & Grabsch, H. I. (2016). Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget, 7(28), 44084-44095. https://doi.org/10.18632/oncotarget.9857

@article{3e4ec819ce884932ae10e49e4f44ee69,

title = "Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma",

keywords = "array CGH, chemotherapy, esophageal adenocarcinoma, prognosis",

author = "Askar Obulkasim and Bauke Ylstra and {van Essen}, {Hendrik F.} and Christian Benner and Sally Stenning and Ruth Langley and William Allum and David Cunningham and Imran Inam and Hewitt, {Lindsay C.} and West, {Nicolas P.} and Meijer, {Gerrit A.} and {van de Wiel}, {Mark A.} and Grabsch, {Heike I.}",

year = "2016",

month = jul,

day = "12",

doi = "https://doi.org/10.18632/oncotarget.9857",

language = "English",

volume = "7",

pages = "44084--44095",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "28",

}

Obulkasim, A, Ylstra, B, van Essen, HF, Benner, C, Stenning, S, Langley, R, Allum, W, Cunningham, D, Inam, I, Hewitt, LC, West, NP, Meijer, GA, van de Wiel, MA & Grabsch, HI 2016, 'Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma', Oncotarget, vol. 7, no. 28, pp. 44084-44095. https://doi.org/10.18632/oncotarget.9857

TY - JOUR

T1 - Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

AU - Obulkasim, Askar

AU - Ylstra, Bauke

AU - van Essen, Hendrik F.

AU - Benner, Christian

AU - Stenning, Sally

AU - Langley, Ruth

AU - Allum, William

AU - Cunningham, David

AU - Inam, Imran

AU - Hewitt, Lindsay C.

AU - West, Nicolas P.

AU - Meijer, Gerrit A.

AU - van de Wiel, Mark A.

AU - Grabsch, Heike I.

PY - 2016/7/12

Y1 - 2016/7/12

KW - array CGH

KW - chemotherapy

KW - esophageal adenocarcinoma

KW - prognosis

U2 - https://doi.org/10.18632/oncotarget.9857

DO - https://doi.org/10.18632/oncotarget.9857

M3 - Article

C2 - 27286451

SN - 1949-2553

VL - 7

SP - 44084

EP - 44095

JO - Oncotarget

JF - Oncotarget

IS - 28

ER -